Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins

Microbial Cell Factories

Volumn 3, Issue , 2004, Pages

  Vallejo, Luis Felipe ^a   Rinas, Ursula ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BUFFER; CHAPERONE; LIPOSOME; PROTEIN PRECURSOR; REAGENT;

BACTERIAL METABOLISM; BINDING AFFINITY; CELL INCLUSION; DIAFILTRATION; DILUTION; DISULFIDE BOND; GEL PERMEATION CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HYDROPHOBICITY; IN VIVO STUDY; ISOLATION PROCEDURE; MICELLE; MOLECULAR WEIGHT; NONHUMAN; PRESSURE; PROCESS DEVELOPMENT; PRODUCT RECOVERY; PROTEIN FOLDING; PROTEIN STABILITY; REVIEW; SOLUBILIZATION; TEMPERATURE;

BACTERIA (MICROORGANISMS);

EID: 13644268136     PISSN: 14752859     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2859-3-11     Document Type: Review

References (157)

1. Carrió MM, Villaverde A: Protein aggregation as bacterial inclusion bodies is reversible. FEBS Lett 2001, 489:29-33.
2. Datar RV, Cartwright T, Rosen C-G: Process economics of animal cell and bacterial fermentations: A case study analysis of tissue plasminogen activator. Bio/Technology 1993, 11:349-357.
3. Qiu J, Swartz JR, Georgiou G: Expression of active human tissue-type plasminogen activator in Escherichia coli. Appl Environ Microbiol 1998, 64:4891-4896.
4. Zhan X, Schwaller M, Gilbert HF, Georgiou G: Facilitating the formation of disulfide bonds in the Escherichia coli periplasm via coexpression of yeast protein disulfide isomerase. Biotechnol Prog 1999, 15:1033-1038.
5. Schäffner J, Winter J, Rudolph R, Schwarz E: Cosecretion of chaperones and low-molecular-size medium additives increases the yield of recombinant disulfide-bridged proteins. Appl Environ Microbiol 2001, 67:3994-400.
6. Manosroi J, Tayapiwatana C, Götz F, Werner RG, Manosroi A: Secretion of active recombinant human tissue plasminogen activator derivatives in Escherichia coli. Appl Environ Microbiol 2001, 67:2657-2664.
7. Manosroi J, Tayapiwatana C, Manosroi A, Beer J, Bergemann K, Werner RG: Lekteplase - a secreted tissue plasminogen activator derivative from Escherichia coli. Arzneim-Forsch 2002, 52:60-66.
8. Martegani E, Forlani N, Mauri I, Porro D, Schleuning WD, Alberghina L: Expression of high levels of human tissue plasminogen activator in yeast under the control of an inducible GAL promoter. Appl Microbiol Biotechnol 1992, 37:604-608.
9. Wiebe MG, Karandikar A, Robson GD, Trinci APJ, Flores Candia J-L, Trappe S, Wallis G, Rinas U, Derkx PMF, Madrid SM, Sisniega H, Faus I, Montijn R, van den Hondel CAMJJ, Punt PJ: Production of tissue plasminogen activator (t-PA) in Aspergillus niger. Biotechnol Bioeng 2001, 76:164-174.
10. Farrell PJ, Behie LA, Iatrou K: Transformed lepidopteran insect cells: New sources of recombinant human tissue plasminogen activator. Biotechnol Bioeng 1999, 64:426-433.
11. Lilie H, Schwarz E, Rudolph R: Advances in refolding of proteins produced in E. coli. Curr Opin Biotechnol 1998, 9:497-501.
12. De Bernardez Clark E: Refolding of recombinant proteins. Curr Opin Biotechnol 1998, 9:157-163.
13. Gergiou G, Valax P: Isolating inclusion bodies from bacteria. Methods Enzymol 1999, 309:48-58.
14. De Bernardez Clark E, Schwarz E, Rudolph R: Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol 1999, 309:217-236.
15. De Bernardez Clark E: Protein refolding for industrial processes. Curr Opin Biotechnol 2001, 12:202-207.
16. Middelberg APJ: Preparative protein refolding. Trends Biotechnol 2002, 20:437-443.
17. Tsumoto K, Ejima D, Kumagai I, Arakawa T: Practical considerations in refolding proteins from inclusion bodies. Protein Expr Purif 2003, 28:1-8.
18. Fahnert B, Lilie H, Neubauer P: Inclusion bodies: Formation and utilization. Adv Biochem Eng/Biotechnol 2004, 89:93-142.
19. Rinas U, Bailey JE: Protein compositional analysis of inclusion bodies produced in recombinant Escherichia coli. Appl Microbiol Biotechnol 1992, 37:609-614.
20. Hagel P, Gerding JJT, Fieggen W, Bloemendal H: Cyanate formation in solutions of urea I. Calculation of cyanate concentrations at different temperature and pH. Biochim Biophys Acta 1971, 243:366-373.
21. Cejka J, Vodražka Z, Salák J: Carbamylation of globin in electrophoresis and chromatography in the presence of urea. Biochim Biophys Acta 1968, 154:589-591.
22. Estapé D, Rinas U: Optimized procedures for purification and solubilization of basic fibroblast growth factor inclusion bodies. Biotechnol Tech 1996, 10:481-484.
23. Iwakura M, Obara K, Kokubu T, Ohashi S, Izutsu H: Expression and purification of growth hormone-releasing factor with the aid of dihydrofolate reductase handle. J Biochem (Tokyo) 1992, 112:57-62.
24. Khan RH, Appa Rao KBC, Eshwari ANS, Totey SM, Panda AK: Solubilization of recombinant ovine growth hormone with retention of native-like secondary structure and its refolding from the inclusion bodies of Escherichia coli. Biotechnol Prog 1998, 14: 22-728.
25. Patra AK, Mukhopadhyay R, Mukhija R, Krishnan A, Garg LC, Panda AK: Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli Protein Expr Purif 2000, 18:182-192.
26. Thatcher DR, Hitchcock A: Protein folding in biotechnology. In Mechanisms of protein refolding Edited by: Pain HR. Oxford: Oxford University Press; 1994:229-254.
27. Puri NK, Crivelli E, Cardamone M, Fiddes R, Bertolini J, Ninham B, Brandon MR: Solubilization of growth hormone and other recombinant proteins from Escherichia coli by using a cationic surfactant. Biochem J 1992, 285:871-879.
28. Kurucz I, Titus JA, Jost CR, Segal DM: Correct disulfide pairing and efficient refolding of detergent-solubilized single-chain Fv proteins from bacterial inclusion bodies. Mol Immunol 1995, 32:1443-1452.
29. Tsumoto K, Umetsu M, Kumagai I, Ejima D, Arakawa T: Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginine. Biochem Biophys Res Commun 2003, 312:1383-1386.
30. Umetsu M, Tsumoto K, Ashish K, Nitta S, Tanaka Y, Adschiri T, Kumagai I: Structural characteristics and refolding of in vivo aggregated hyperthermophilic archaeon proteins. FEBS Lett 2004, 557:49-56.
31. Tokatlidis K, Dhurjati P, Millet J, Béguin P, Aubert J-P: High activity of inclusion bodies formed in Escherichia coli overproducing Clostridium thermocellum endoglucanase D. FEBS Lett 1991, 282:205-208.
32. Zettlmeissl G, Rudolph R, Jaenicke R: Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 1. Physical properties and kinetics of aggregation. Biochemistry 1979, 18:5567-5575.
33. Kiefhaber T, Rudolph R, Kohler H-H, Buchner J: Protein aggregation in vitro and in vivo: A quantitative model of the kinetic competition between folding and aggregation. Bio/Technology 1991, 9:825-829.
34. Goldberg ME, Rudolph R, Jaenicke R: A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. Biochemistry 1991, 30: 790-2797.
35. De Bernardez Clark E, Hevehan D, Szela S, Maachupalli-Reddy J: Oxidative renaturation of hen egg-white lysozyme. Folding vs aggregation. Biotechnol Prog 1998, 14:47-54.
36. Tran-Moseman A, Schauer N, De Bernardez Clark E: Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor. Protein Expr Purif 1999, 16:181-189.
37. Katoh S, Katoh Y: Continous refolding of lysozyme with fedbatch addition of denatured protein solution. Process Biochem 2000, 35:1119-1124.
38. Gu Z, Su Z, Janson J-C: Urea gradient size-exclusion chromatography enhanced the yield of lysozyme refolding. J Chromatogr A 2001, 918:311-318.
39. Tikhonov RV, Pechenov SE, Belacheu IA, Yakimov SA, Klyushnichenko VE. Tunes H, Thiemann JE, Vilela L, Wulfson AN: Recombinant human insulin IX. Investigation of factors, influencing the folding of fusion protein-S-sulfonates, biotechnological precursors of human insulin. Protein Express Purif 2002, 26:187-193.
40. Vallejo LF, Rinas U: Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration. Biotechnol Bioeng 2004, 85:601-609.
41. Ho JGS, Middelberg APJ, Ramage P, Kocher HP: The likelihood of aggregation during protein renaturation can be assessed using the second virial coefficient. Protein Sci 2003, 12: 08-716.
42. Maachupalli-Reddy J, Kelley BD, De Bernardez Clark E: Effect of inclusion body contaminants on the oxidative renaturation of hen egg white lysozyme. Biotechnol Prog 1997, 13:144-150.
43. Batas B, Schiraldi C, Chaudhuri JB: Inclusion body purification and protein refolding using microfiltration and size exclusion chromatography. J Biotechnol 1999, 68:149-158.
44. Müller C, Rinas U: Renaturation of heterodimeric platelet-derived growth factor from inclusion bodies of recombinant Escherichia coli using size-exclusion chromatography. J Chromatogr A 1999, 855:203-213.
45. Buchner J, Pastan I, Brinkmann U: A method for increasing the yield of properly folded recombinant fusion proteins: Single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal Biochem 1992, 205:263-270.
46. Fischer B, Perry B, Sumner I, Goodenough P: A novel sequential procedure to enhance the renaturation of recombinant protein from Escherichia coli inclusion bodies. Protein Eng 1992, 5:593-596.
47. Terashima M, Suzuki K, Katoh S: Effective refolding of fully reduced lysozyme with a flow-type reactor. Process Biochem 1996, 31:341-345.
48. Maeda Y, Koga H, Yamada H, Ueda T, Imoto T: Effective renaturation of reduced lysozyme by gentle removal of urea. Protein Eng 1995, 8:201-205.
49. Varnerin JP, Smith T, Rosenblum CI, Vongs A, Murphy BA, Nunes C, Mellin TN, King JJ, Burgess BW, Junker B, Chou M, Hey P, Frazier E, MacIntyre DE, van der Ploeg LHT, Tota MR: Production of leptin in Escherichia coli: A comparison of methods. Protein Expr Purif 1998, 14:335-342.
50. West SM, Chaudhuri JB, Howell JA: Improved protein refolding using hollow-fibre membrane dialysis. Biotechnol Bioeng 1998, 57:590-599.
51. Yoshii H, Furuta T, Yonehara T, Ito D, Linko Y-Y, Linko P: Refolding of denatured/reduced lysozyme at high concentration with diafiltration. Biosci Biotechnol Biochem 2000, 64: 159-1165.
52. Gu Z, Weidenhaupt M, Ivanova N, Pavlov M, Xu B, Su Z-G, Janson JC: Chromatographic methods for the isolation of, and refolding of proteins from, Escherichia coli inclusion bodies. Protein Express Purif 2002, 25:174-179.
53. Horowitz PM, Simon D: The enzyme rhodanese can be reactivated after denaturation in guanidium chloride. J Biol Chem 1986, 261:13887-13891.
54. Sørensen HP, Sperling-Petersen HU, Mortensen KK: Dialysis strategies for protein refolding: Preparative streptavidin production. Protein Express Purif 2003, 31:149-154.
55. Werner MH, Clore GM, Gronenborn AM, Kondoh A, Fisher RJ: Refolding proteins by gel filtration chromatography. FEBS Lett 1994, 345:125-130.
56. Batas B, Chaudhuri JB: Protein refolding at high concentration using size-exclusion chromatography. Biotechnol Bioeng 1996, 50:16-23.
57. Batas B, Chaudhuri JB: Considerations of sample application and elution during size-exclusion chromatography-based protein refolding. J Chromatogr A 1999, 864:229-236.
58. Fahey EM, Chaudhuri JB: Refolding of low molecular weight urokinase plasminogen activator by dilution and size exclusion chromatography-a comparative study. Sep Sci Technol 2000, 35: 743-1760.
59. Li M, Poliakov A, Danielson UH, Su Z, Janson JC: Refolding of a recombinant full-length non-structural (NS3) protein from hepatitis C virus by chromatographic procedures. Biotechnol Lett 2003, 25:1729-1734.
60. Schlegl R, Iberer G, Machold C, Necina R, Jungbauer A: Continuous matrix-assisted refolding of proteins. J Chromatogr A 2003, 1009:119-132.
61. Lanckriet H, Middelberg APJ: Continuous chromatographic protein refolding. J Chromatogr A 2004, 1022:103-113.
62. Liu H-S, Chang C-K: Chaperon solvent plug to enhance protein refolding in size exclusion chromatography. Enzyme Microb Technol 2003, 33:424-429.
63. Fahey EM, Chaudhuri JB, Binding P: Refolding and purification of a urokinase plasminogen activator fragment by chromatography. J Chromatogr B 2000, 737:225-235.
64. Gu Z, Zhu X, Ni S, Zhou H, Su Z: Inhibition of aggregation by media selection, sample loading and elution in size exclusion chromatographic refolding of denatured bovine carbonic anhydrase B. J Biochem Biophys Methods 2003, 56:165-175.
65. Suttnar J, Dyr JE, Hamsšíková E, Novák J, Vonka V: Procedure for refolding and purification of recombinant proteins from Escherichia coli inclusion bodies using a strong anion exchanger. J Chromatogr B 1994, 656:123-126.
66. Creighton TE: Folding of proteins adsorbed reversibly to ion-exchange resins. UCLA Symp Mol Cell Biol 1986, 39: 49-257.
67. Li M, Zhang G, Su Z: Dual gradient ion-exchange chromatography improved refolding yield of lysozyme. J Chromatogr A 2002, 959:113-120.
68. Negro A, Onisto M, Grassato L, Caenazzo C, Garbisa S: Recombinant human TIMP-3 from Escherichia coli: Synthesis, refolding physico-chemical and functional insights. Protein Eng 1997, 10:593-599.
69. Zouhar J, Nanak E, Brzobohatý B: Expression, single-step purification, and matrix-assisted refolding of a maize cytokinin glucoside-specific β-glucosidase. Protein Expr Purif 1999, 17:153-162.
70. Rehm BHA, Qi Q, Beermann BB, Hinz H-J, Steinbüchel A: Matrix assisted in vitro refolding of Pseudomonas aeruginosa class II polyhydroxylalkanoate synthase from inclusion bodies produced in recombinant Escherichia coli. Biochem J 2001, 358: 63-268.
71. Stempfer G, Höll-Neugebauer B, Rudolph R: Improved refolding of an immobilized fusion protein. Nature Biotechnol 1996, 14:329-334.
72. Cho TH, Ahn SJ, Lee EK: Refolding of protein inclusion bodies directly from E. coli homogenate using expanded bed adsorption chromatography. Bioseparation 2001, 10:189-96.
73. Berdichevsky Y, Lamed R, Frenkel D, Gophna U, Bayer EA, Yaron S, Shoham Y, Benhar I: Matrix-assisted refolding of single-chain Fv-cellulose binding domain fusion proteins. Protein Expr Purif 1999, 17:249-259.
74. Geng X, Chang X: High-performance hydrophobic interaction chromatography as a tool for protein refolding. J Chromatogr A 1992, 599:185-194.
75. Geng X, Quan B: Mechanism of simultaneously refolding and purification of proteins by hydrophobic interaction chromatographic unit and aplications. Sci China B 2002, 45:655-669.
76. Bai Q, Kong Y, Geng X: Studies on renaturation with simultaneous purification of recombinant human proinsulin from E. coli with high perfomance hydrophobic interaction chromatography. J Liq Chromatogr R T 2003, 26:683-695.
77. Gong B, Wang L, Wang C, Geng X: Preparation of hydrophobic interaction chromatographic packings based on monodisperse poly(glycidylmethacrylate-co-ethylenedimethacrylate) beads and their application. J Chromatogr A 2004, 1022:33-39.
78. Wang C, Geng X, Wang D, Tian B: Purification of recombinant bovine normal prion protein PrP(104-242) by HPHIC. J Chromatogr B 2004, 806:185-190.
79. Privalov PL: Physical basis of the stability of the folded conformations of proteins. In Protein folding Edited by: Creighton TE. New York: W. H. Freeman and Company; 1992:83-126.
80. Robinson CR, Sligar SG: Hydrostatic and osmotic pressure as tools to study macromolecular recognition. Methods Enzymol 1995, 259:395-427.
81. Foguel D, Robinson CR, de Sousa PC Jr, Silva JL, Robinson AS: Hydrostatic pressure rescues native protein from aggregates. Biotechnol Bioeng 1999, 63:552-558.
82. St John RJ, Carpenter JF, Randolph TW: High pressure fosters protein refolding from aggregates at high concentrations. Proc Natl Acad Sci USA 1999, 96:13029-13033.
83. St John RJ, Carpenter JF, Balny C, Randolph TW: High pressure refolding of recombinant human growth hormone from insoluble aggregates: Structural transformations, kinetic barriers and energetics. J Biol Chem 2001, 276:46856-46863.
84. Cleland JL, Wang DIC: Cosolvent assisted protein refolding. Bio/Technology 1990, 8:1274-1278.
85. Goldberg ME, Expert-Bezançon N, Vuillard L, Rabilloud T: Non-detergent sulphobetaines: A new class of molecules that facilitate in vitro renaturation. Folding & Design 1995, 1:21-27.
86. Vicik SM: Methods of refolding proteins by use of zwitterionic low molecular weight agents. . 1999 WO 99/18196
87. Vallejo LF, Brokelmann M, Marten S, Trappe S, Cabrera-Crespo J, Hoffmann A, Gross G, Weich HA, Rinas U: Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. J Biotechnol 2002, 94:185-194.
88. Kuboi R, Morita S, Ota H, Umakoshi H: Protein refolding using stimuli-responsive polymer-modified aqueous two-phase systems. J Chromatogr B 2000, 743:215-223.
89. Yoshimoto N, Hashimoto T, Felix MM, Umakoshi H, Kuboi R: Artificial chaperone-assisted refolding of bovine carbonic anhydrase using molecular assemblies of stimuli-responsive polymers. Biomacromolecules 2003, 4:1530-1538.
90. Arakawa T, Tsumoto K: The effects of arginine on refolding of aggregated proteins: Not facilitate refolding, but suppress aggregation. Biochem Biophys Res Commun 2003, 304:148-152.
91. Tandon S, Horowitz PM: Detergent-assisted refolding of guanidium chloride-denatured rhodanese. J Biol Chem 1987, 262:4486-4491.
92. Zardeneta G, Horowitz PM: Micelle-assisted protein folding. J Biol Chem 1992, 267:5811-5816.
93. Yoshimoto M, Kuboi R: Oxidative refolding of denatured/reduced lysozyme utilizing the chaperone-like function of liposomes and immobilized liposome chromatography. Biotechnol Prog 1999, 15:480-487.
94. Yoshimoto M, Shimanouchi T, Umakoshi H, Kuboi R: Immobilized liposome chromatography for refolding and purification of protein. J Chromatogr B 2000, 743:93-99.
95. Zardeneta G, Horowitz PM: Detergent, liposome, and micelle-assisted protein refolding. Anal Biochem 1994, 223: -6.
96. Zardeneta G, Horowitz PM: Protein refolding at high concentrations using detergent/phospholipid mixtures. Anal Biochem 1994, 218:392-398.
97. Hagen AJ, Hatton TA, Wang DIC: Protein refolding in reversed micelles. Biotechnol Bioeng 1990, 35:955-965.
98. Hashimoto Y, Ono T, Goto M, Hatton TA: Protein refolding by reversed micelles utilizing solid-liquid extraction technique. Biotechnol Bioeng 1998, 57:620-623.
99. Goto M, Hashimoto Y, Fujita T-A, Ono T, Furusaki S: Important parameters affecting efficiency of protein refolding by reversed micelles. Biotechnol Prog 2000, 16:1079-1085.
100. Vinogradov AA, Kudryashova EV, Levashov AV, van Dongen WMAM: Solubilization and refolding of inclusion body proteins in reverse micelles. Anal Biochem 2003, 320:234-238.
101. Ewalt KL, Hendrick JP, Houry WA, Hartl FU: In vivo observation of polypeptide flux through the bacterial chaperonin system. Cell 1997, 90:491-500.
102. Hartl FU: Molecular chaperones in cellular protein folding. Nature 1996, 381:571-580.
103. Thomas JG, Ayling A, Baneyx F: Molecular chaperones, folding catalysts, and the recoverey of active recombinant proteins from E. coli. Appl Biochem Biotechnol 1997, 66:197-238.
104. Buchner J, Brinkmann U, Pastan I: Renaturation of a single-chain immunotoxin facilitated by chaperones and protein disulfide isomerase. Bio/Technology 1992, 10:682-685.
105. Altamirano MM, Golbik R, Zahn R, Buckle AM, Fersht AR: Refolding chromatography with immobilized mini-chaperones. Proc Natl Acad Sci USA 1997, 94:3576-3578.
106. Gao Y-G, Guan Y-X, Yao S-J, Cho M-G: On-column refolding of recombinant human interferon-γ with an immobilized chaperone fragment. Biotechnol Prog 2003, 19:915-920.
107. Rozema D, Gellman SH: Artificial chaperones: Protein refolding via sequential use of detergent and cyclodextrin. J Am Chem Soc 1995, 117:2373-2374.
108. Rozema D, Gellman SH: Artificial chaperone-assisted refolding of carbonic anhydrase B*. J Biol Chem 1996, 271: 478-3487.
109. Rozema D, Gellman SH: Artificial chaperone-assisted refolding of denatured-reduced lysozyme: Modulation of the competition between renaturation and aggregation. Biochemistry 1996, 35: 5760-15771.
110. Nath D, Rao M: Arificial chaperone mediated refolding of xylanase from an alkalopholic thermophlic Bacillus sp. Eur J Biochem 2001, 268:5471-5478.
111. Nomura Y, Ikeda M, Yamaguchi N, Aoyama Y, Akiyoshi K: Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone. FEBS Lett 2003, 553:271-276.
112. Daugherty DL, Rozema D, Hanson PE, Gellman SH: Artificial chaperone-assisted refolding of citrate synthase. J Biol Chem 1998, 273:33961-33971.
113. Machida S, Ogawa S, Xiaohua S, Takaha T, Fujii K, Hayashi K: Cycloamylose as an efficient artificial chaperone for protein refolding. FEBS Lett 2000, 486:131-135.
114. Mannen T, Yamaguchi S, Honda J, Sugimoto S, Nagamune T: Expanded-bed protein refolding using a solid-phase artificial chaperone. J Biosci Bioeng 2001, 91:403-408.
115. Simon SM, Peskin CS, Oster GF: What drives the translocations of proteins. Proc Natl Acad Sci USA 1992, 89: 770-3774.
116. Yoshii H, Furuta T, Yasunishi A, Kojima T: Rapid renaturation of denatured and aggregated proteins using liquid paraffin as a pseudolipid bilayer membrane. Biotechnol Bioeng 1994, 43:57-63.
117. Shinde U, Inouye M: Intramolecular chaperones and protein folding. Trends Biochem Sci 1993, 18:442-446.
118. Zhu X, Ohta Y, Jordan F, Inouye M: Pro-sequence of subtilisin can guide the refolding of denatured subtilisin in an intermolecular process. Nature 1989, 339:483-484.
119. Beer H-D, Wohlfahrt G, Schmid RD, McCarthy JEG: The folding and activity of the extracellular lipase of Rhizopus oryzae are modulated by a prosequence. Biochem J 1996, 319: 51-359.
120. Tang B, Nirasawa S, Kitaoka M, Marie-Claire C, Hayashi K: General function of N-terminal propeptide on assisting protein folding and inhibiting catalytic activity based on observations with a chimeric thermolysin-like protease. Biochem Biophys Res Commun 2003, 301:1093-1098.
121. Rattenholl A, Lilie H, Grossmann A, Stern A, Schwarz E, Rudolph R: The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies. Eur J Biochem 2001, 268:3296-3303.
122. Jin H-J, Dunn MA, Borthakur D, Kim YS: Refolding and purification of unprocessed porcine myostatin expressed in Escherichia coli. Protein Expr Purif 2004, 35:1-10.
123. Hahm MS, Chung BH: Refolding and purification of yeast carboxypeptidase Y expressed as inclusion bodies in Escherichia coli Protein Expr Purif 2001, 22:101-107.
124. Ermolenko DN, Zherdev AV, Dzantiev BB, Popov VO: Antiperoxidase antibodies enhance refolding of horseradish peroxidase. Biochem Biophys Res Commun 2002, 291:959-965.
125. Xu Q, Xie Z, Ding J, Lin S-X, Xu G: Monoclonal antibodies assisting refolding of firefly luciferase. Protein Sci 2004, 13:1851-1858.
126. Ahmed AK, Schaffer SW, Wetlaufer DB: Nonenzymic reactivation of reduced bovine pancreatic ribonuclease by air oxidation and by glutathione oxidoreduction buffers. J Biol Chem 1975, 250:8477-8482.
127. Menzella HG, Gramajo HC, Ceccarelli EA: High recovery of prochymosin from inclusion bodies using controlled air oxidation. Protein Express Purif 2002, 25:248-255.
128. Rudolph R, Lilie H: In vitro folding of inclusion body proteins. FASEB J 1996, 10:49-56.
129. Wetlaufer DB, Branca PA, Chen G-X: The oxidative folding of proteins by disulfide plus thiol does not correlate with redox potential. Protein Eng 1987, 1:141-146.
130. Misawa S, Kumagai I: Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies. Biopolymers 1999, 51:297-307.
131. DeCollo TV, Lees WJ: Effects of aromatic thiols on thioldisulfide interchange reactions that occur during protein folding. J Org Chem 2001, 66:4244-4249.
132. Gough JD, Williams RH Jr, Donofrio AE, Lees WJ: Folding disulfide-containing proteins faster with an aromatic thiol. J Am Chem Soc 2002, 124:3885-3892.
133. Shimizu H, Fujimoto K, Kawaguchi H: Refolding of protein using thiol-carrying latex particles. Colloid Surface A 1999, 153:421-427.
134. Shimizu H, Fujimoto K, Kawaguchi H: Renaturation of reduced ribonuclease A with a microsphere-induced refolding system. Biotechnol Prog 2000, 16:248-253.
135. Kuhelj R, Dolinar M, Pungercar J, Turk V: The preparation of cataytically active cathepsin B from its precursor expressed in Escherichia coli in the form of inclusion bodies. Eur J Biochem 1995, 229:533-539.
136. Mukhopadhyay A: Reversible protection of disulfide bonds followed by oxidative folding render recombinant hCGβ highly immunogenic. Vaccine 2000, 18:1802-1810.
137. Rudolph R: Renaturation of recombinant, disulfide-bonded proteins from "inclusion bodies". In Modern methods in protein and nucleic acid analysis Edited by: Tschesche H. Berlin New York: Walter de Gruyter; 1990:149-171.
138. Gilbert HF: Protein disulfide isomerase and assisted protein folding. J Biol Chem 1997, 272:29399-29402.
139. Lilie H, McLaughlin S, Freedman R, Buchner J: Influence of protein disulfide isomerase (PDI) on antibody folding in vitro. J Biol Chem 1994, 269:14290-14296.
140. Shin H-C, Scheraga HA: Catalysis of the oxidative folding of bovine pancreatic ribonuclease A by protein disulfide isomerase. J Mol Biol 2000, 300:995-1003.
141. Singh RR, Rao AGA: Reductive unfolding and oxidative refolding of a Bowman-Birk inhibitor from horsegram seeds (Dolichos biflorus): Evidence for 'hyperreactive' disulfide bonds and rate-limiting nature of disulfide isomerization in folding. Biochim Biophys Acta 2002, 1597:280-291.
142. Hawkins HC, Freedman RB: The effect of denaturants on PDI conformation and activity. Biochem Soc Trans 1995, 23:65S.
143. Cabrele C, Fiori S, Pegoraro S, Moroder L: Redox-active cyclic bis(cysteinyl)peptides as catalysts for in vitro oxidative protein folding. Chem Biol 2002, 9:731-740.
144. Woycechowsky KJ, Wittrup KD, Raines RT: A small-molecule catalyst of protein folding in vitro and in vivo. Chem Biol 1999, 6:871-879.
145. Woycechowsky KJ, Hook BA, Raines RT: Catalysis of protein folding by an immobilized small-molecule dithiol. Biotechnol Prog 2003, 19:1307-1314.
146. Winter J, Lilie H, Rudolph R: Recombinant expression and in vitro folding of proinsulin are stimulated by the synthetic dithiol Vectrase-P. FEMS Microbiol Lett 2002, 213:225-230.
147. Hart RA, Lester PM, Reifsnyder DH, Ogez JR, Builder SE: Large scale, in situ isolation of periplasmic IGF-I from E. coli Bio/Technology 1994, 12:1113-1116.
148. Falconer RJ, O'Neill BK, Middelberg APJ: Chemical treatment of Escherichia coli: 3. Selective extraction of a recombinant protein from cytoplasmic inclusion bodies in intact cells. Biotechnol Bioeng 1999, 62:455-460.
149. Choe W-S, Clemmitt RH, Chase HA, Middelberg APJ: Coupling of chemical extraction and expanded-bed adsorption for simplified inclusion-body processing: Optimization using surface plasmon resonance. Biotechnol Bioeng 2003, 81:221-232.
150. Choe W, Clemmitt R, Rito-Palomares M, Chase HA, Middelberg APJ: Bioprocess intensification: A radical new process for recovering inclusion body protein. Trans IChemE 2002, 80:45-50.
151. Choe W-S, Clemmitt RH, Chase HA, Middelberg APJ: Comparison of histidine-tag capture chemistries for purification following chemical extraction. J Chromatogr A 2002, 953: 11-121.
152. Heeboll-Nielsen A, Choe W-S, Middelberg APJ, Thomas ORT: Efficient inclusion body processing using chemical extraction and high gradient magnetic fishing. Biotechnol Prog 2003, 19: 87-898.
153. Lee CT, Morreale G, Middelberg APJ: Combined in-fermenter extraction and cross-flow microfiltration for improved inclusion body processing. Biotechnol Bioeng 2004, 85:103-113.
154. Ahn JH, Lee YP, Rhee JS: Investigation of refolding condition for Pseudomonas fluorescens lipase by response surface methodology. J Biotechnol 1997, 54:151-160.
155. Lu H, Zhang H, Wang Q, Yuan H, He W, Zhao Z, Li Y: Purification, refolding of hybrid hIFNγ-kringle 5 expressed in Escherichia coli. Curr Microbiol 2001, 42:211-216.
156. Ho JGS, Middelberg APJ: Estimating the potential refolding yield of recombinant proteins expressed as inclusion boidies. Biotechnol Bioeng 2004, 87:584-592.
157. Trésaugues L, Collinet B, Minard P, Henckes G, Aufrère R, Blondeau K, Liger D, Zhou C-Z, Janin J, van Tilbeurgh H, Quevillon-Cheruel S: Refolding strategies from inclusion bodies in a structural genomics project. J Struct Funct Genomics 2004, 5: 95-204.